Biotronik said today that China’s National Medical Products Administration approved its Orsiro drug-eluting stent.

Orsiro is a cobalt-chromium stent that elutes the drug sirolimus via the Berlin-based company’s Biolute bioabsorbable polymer coating. Biotronik said it plans to have Orsiro on the Chinese market “in the coming months.”

Get the full story at our sister site, Drug Delivery Business News